NEW YORK—Bayer AG plans to spend $1 billion on drug research and development in the U.S. this year as it works to double its sales in the country by the end of the decade, Bayer’s top U.S. pharmaceutical executive told Reuters. Sebastian Guth, president of Bayer’s pharmaceuticals business in the Americas, also said in an…
Bayer Plans to Spend $1 Billion on US Pharma R&D in 2023: US Pharma Head
Bayer Paying $40 Million to Settle Lawsuits Over False Claims
September 5, 2022
admin
BayerBig PharmaBrightBusiness & MarketsCompaniescorporate fraudhealthHealth NewsJudiciaryNews & Discoveriespharmaceutical companyUSUS News
0 Comment
Pharmaceutical manufacturer Bayer Corporation and its related entities are to pay $40 million to resolve two whistleblower lawsuits filed by a former employee. The lawsuits were filed by Laurie Simpson who used to work in Bayer’s marketing department. They are related to false claims made by the company about three of its drugs: Trasylol, Avelox,…
Bayer’s Agriculture Unit, Consumer Health Drive Outlook Hike
FRANKFURT, Germany—Agriculture and pharmaceuticals company Bayer on Thursday lifted its 2022 earnings guidance on strong demand from farmers for its seeds and crop chemicals and higher sales of consumer health products. Bayer is now targeting earnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for special items, of about 13 billion euros ($13.21 billion), based…
US Supreme Court Again Nixes Bayer Challenge to Weedkiller Suits
The U.S. Supreme Court on Monday rejected another Bayer AG bid to dismiss litigation alleging that its Roundup weedkiller causes cancer as the German pharmaceutical and chemical giant tries to avoid potentially billions of dollars in damages. The justices turned away a Bayer appeal and left in place a lower court decision upholding an $87…
Bayer to Invest 2 Billion Euros in Drug Production Over Next 3 Years
FRANKFURT—German drugmaker Bayer said it would invest around 2 billion euros ($2.23 billion) at pharmaceutical manufacturing sites over the next three years, mainly to bolster production of biotechnology drugs as well as cell and gene therapies. The sites to be upgraded include Berkeley, California, as well as Berlin, Leverkusen, and Bergkamen in Germany. In addition,…
Bayer Reaches $80 Million PCB Contamination Settlement With Ohio
Bayer AG reached an $80 million settlement with Ohio to resolve environmental damage allegedly caused by polychlorinated biphenyls, or PCBs, made by the company’s Monsanto business, the state attorney general said on Thursday. The funds from the German company, which did not admit liability, will be used for environmental cleanup, the attorney general said. Monsanto,…
Bayer in Gene Therapy Collaboration With Mammoth Biosciences
FRANKFURT—Bayer on Monday struck a partnership deal with Mammoth Biosciences to develop therapeutic tools based on CRISPR/CAS9 gene editing as the German drug maker seeks to widen its cell and gene therapy development efforts. Unlisted U.S. biotech firm Mammoth will initially receive $40 million from Bayer plus potential milestone payments of more than $1 billion…
Supreme Court Could Decide Fate of Monsanto/Bayer RoundUp Cancer Suits
December 21, 2021
admin
BayercancerEnvironmentEPAGlyphosateHealth & SafetyHealth NewsJudiciaryLifestyleMind & BodyMonsantonon-Hodgkins lymphomapesticidesRoundupScienceScience NewsSupreme CourtTrumpU.S. Chamber of CommerceUS
0 Comment
On Dec. 13, the Supreme Court asked the Solicitor General to offer the United States’ views on “Monsanto vs. Hardeman”—the latest move in what could be a landmark case for multibillion-dollar litigation linking the pesticide RoundUp to non-Hodgkin’s lymphoma, if the Supreme Court agrees to review the case. After a call for the views of…
Jury Orders Bayer to Pay $62 Million Over Contaminated US School Building
November 11, 2021
admin
BayerBusiness & EconomyCompaniescontaminatedMonsantoSky Valley Education CenterU.S. School BuildingUSUS News
0 Comment
A U.S. jury on Wednesday ordered Bayer AG to pay $62 million to students and others who say they were exposed to toxic chemicals made by the company’s predecessor, Monsanto Co, in a school building in Washington state. The verdict was the second against Bayer over polychlorinated biphenyls, or PCBs, at the Sky Valley Education…
Bayer Blasts ‘Unscientific’ Rejection by Mexican Regulator of GMO Corn Permit
October 9, 2021
admin
AmericasBayerBusiness & EconomyCompaniescornEuropeGMOMexicanpermitregulatorrejectionUnscientificWorld
0 Comment
MEXICO CITY—Bayer is evaluating its legal options after Mexican health regulators for the first time rejected a GMO corn permit it was seeking, the German pharmaceutical and crop science giant said in a statement to Reuters on Friday, blasting the decision as “unscientific.” Reuters reported earlier in the day that regulator Cofepris rejected the corn…
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta